Cooking meats at high temperatures and for long duration produces heterocyclic amines and other mutagens. These meat-derived mutagenic compounds have been hypothesized to increase risk of colorectal neoplasia, but prospective data are unavailable. We examined the association between intakes of the heterocyclic amines 2-amino-3,8-dimethylimidazo[4,5,-f]quinoxaline (MeIQx), 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), 2-amino-3,4,8-trimethylimidazo[4,5,-f]quinoxaline (DiMeIQx), and meat-derived mutagenicity (MDM) and risk of distal colon adenoma using a cooking method questionnaire administered in 1996 in the Health Professionals Follow-up Study cohort. Between 1996 and 2002, 581 distal colon adenoma cases were identified. Higher intake of MDM was marginally associated with increased risk of distal adenoma [fourth versus lowest quintile: odds ratio (OR), 1.39; 95% confidence interval (95% CI), 1.05-1.84; highest versus lowest quintile: OR, 1.29; 95% CI, 0.97-1.72; Ptrend = 0.08]. Adjusting for total red meat or processed meat intake did not explain those associations. Our data also suggested a positive association between higher MeIQx (highest versus lowest quintile: OR, 1.28; 95% CI, 0.95-1.71; Ptrend = 0.22) and risk of adenoma, but this association was attenuated after adjusting for processed meat intake. DiMeIQx and PhIP did not seem to be associated with risk of adenoma. In conclusion, higher consumption of mutagens from meats cooked at higher temperature and longer duration may be associated with higher risk of distal colon adenoma independent of overall meat intake. Because mutagens other than heterocyclic amines also contribute to MDM, our results suggest that mutagens other than heterocyclic amines in cooked meats may also play a role in increasing the risk of distal adenoma. (Cancer Epidemiol Biomarkers Prev 2006;15(6):1120–5)

In many epidemiologic studies, meat consumption, particularly red meat, has been associated with higher risk of colorectal cancers or adenomas (1-4). Meat may be involved in colorectal carcinogenesis via several biological mechanisms. One possible mechanism involves the formation of heterocyclic amines, which are produced when meats are cooked at high temperatures and for long duration (5). Although heterocyclic amines are mutagenic in animal and in vitro studies and are carcinogenic in animal studies (5), results from epidemiologic studies of cooking methods and risk of colorectal cancers or their precursors colorectal adenoma (6, 7) have not been consistent possibly due in part to confounding by other components of meat and possible misclassification of intake (2, 8). Heterocyclic amine concentrations in cooked meats increase with increasing temperature and duration of cooking but also depend on cooking methods and type of meat (5, 9). Therefore, studying cooking methods alone as a marker for heterocyclic amine intake may not adequately assess heterocyclic amine exposure (8).

Recently, Sinha et al. developed a method to estimate heterocyclic amine in specific types of meat using proxies for high-temperature cooking and time. Heterocyclic amine intake can be calculated based on these measurements and dietary intake of specific types of meat prepared with different cooking methods and at various doneness levels (5, 10-13). In addition to heterocyclic amine measurements, the database developed by Sinha et al. (http://www.charred.cancer.gov) also contains data on meat-derived mutagenicity (MDM). MDM measures overall mutagenic activity in cooked meat (14, 15) and also increases with higher cooking temperature and duration (http://www.charred.cancer.gov). Thus, in addition to the mutagenic activity due to heterocyclic amines, MDM incorporates mutagenic activities from other compounds found in cooked meats (15). Epidemiologic data on heterocyclic amine or MDM intake and risk of colon or colorectal cancers or adenomas are sparse. Three U.S. case-control studies have found that higher intakes of certain heterocyclic amines may increase risk of colon or colorectal cancers or adenomas (8, 15, 16). One case-control study from Sweden did not observe an overall association between heterocyclic amine intake and risk of colon cancer (17) but found some suggestion of an increased colon cancer risk at the very high end of total heterocyclic amine intake (>1,900 ng/d; ref. 17). Only one case-control study has examined the association between heterocyclic amine intake and MDM and risk of colorectal adenoma (15). In that study, higher intake of 2-amino-3,4,8-trimethylimidazo[4,5,-f]quinoxaline (DiMeIQx), 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), and MDM were associated with higher risk of colorectal adenoma (15). However, assessing exposure after diagnosis of the disease raises the concern that bias in the recall of dietary habits may explain reported associations.

To address this concern, we examined the associations between heterocyclic amine and MDM intake and meat intake in a prospective manner using data from a cooking method questionnaire and food frequency questionnaires (FFQ) administered in the Health Professionals Follow-up Study (HPFS) cohort.

Study Population

The HPFS cohort was formed in 1986 when 51,129 male U.S. health professionals returned a baseline questionnaire on medical history and lifestyle factors. A 131-item FFQ was included with the baseline questionnaire (18). Follow-up questionnaires on medical history and lifestyle factors were mailed every 2 years and additional FFQs were included every 4 years. In 1996, a section requesting information on typical cooking methods was included in the regular biennial follow-up questionnaire. This study was approved by the Human Subjects Committee of the Harvard School of Public Health.

We excluded men with history of ulcerative colitis or cancer (except for nonmelanoma skin cancer and organ-confined prostate cancer) or colorectal polyps before 1996, men who did not respond to the 1996 questionnaires, and those who had left the entire cooking method section blank, did report doneness but not frequency of meat intake of at least one cooked meat item, or did not have information on bacon intake from the 1994 FFQ (see below). Colorectal adenomas, which in most cases are asymptomatic, are mainly detected during routine screening endoscopies or other endoscopies done for adenoma unrelated symptoms. Therefore, after exclusions, our analysis was restricted to 14,032 men who had a large bowel endoscopy between 1996 (the year the cooking method questionnaire was administered) and 2002.

Ascertainment of Colon Adenoma Cases

For men who reported a diagnosis of colorectal polyp on their biennial follow-up questionnaire, we mailed a consent form with a request to review their medical records. These medical records were reviewed by study investigators who extracted information on location, histology, and size of the polyp. All adenoma cases for analysis had to be confirmed by pathology reports. Because we do not know whether a participant who underwent endoscopy had a sigmoidoscopy alone (a sigmoidoscopy only examines the distal part of the colorectum), only distal colon adenomas were included in our analysis. We did not include rectal adenomas because the etiology of colon and rectal cancer may differ (19) and numbers were insufficient to consider rectal cases separately.

Of the 14,032 men who had a large bowel endoscopy between 1996 and 2002, a total of 581 distal colon adenomas were diagnosed between 1996 and 2002. The remaining 13, 451 participants, including those participants who were diagnosed with proximal and/or rectal adenoma, were treated as noncases.

Charred Database

The Charred Database developed by Sinha et al. is an online database that contains data on heterocyclic amine and MDM (http://www.charred.cancer.gov). 2-Amino-3,8-dimethylimidazo[4,5,-f]quinoxaline (MeIQx), DiMeIQx, and PhIP were measured in meat samples applying a method described by Gross and Gruter (20). The mutagenic activity of the meat sample extracts were determined by applying the Ames/Salmonella test (14, 21).

Assessment of Diet, Meat, and Heterocyclic Amine Intake

We computed nutrient intake by multiplying the nutrient content of foods with the reported frequency of intake of each food from the 1986, 1990, 1994, and 1998 FFQs and applied the residuals method to calculate energy-adjusted nutrient intakes (22). We reported the validation and reproducibility of the FFQs administered in this cohort in previous publications (23-25). Cumulative updated nutrient intake was computed by averaging the nutrient intakes from all available questionnaires (1986, 1990, 1994, and 1998) before the beginning of each 2-year follow-up interval (22). We used cumulative average intake to enhance our estimate of long-term dietary intake (22).

The cooking method questions in the 1996 questionnaire were based on results from a previous pilot study, which determined the group of cooking method questions that would best predict heterocyclic amine intake in this specific cohort (26) and included questions on frequency of intake (never, <1/mo, 1/mo, 2-3/mo, 1/wk, 2-3/wk, and ≥4/wk) and outside appearance (depending on type of meat: lightly browned, medium browned, well browned, and blackened/charred) of meats and fish. The items included pan-fried, broiled, and grilled chicken, broiled fish, roast beef, pan-fried steak, grilled or barbecued steak, and homemade beef gravy. We also included questions on whether the chicken was cooked with skin on and whether the skin was eaten. Our previous pilot study found limited variation in the reported doneness of cooking bacon (26). Therefore, frequency of fried bacon intake was based on bacon intake from the 1994 FFQ and assumed to be prepared at higher doneness levels (medium browned; ref. 26). We estimated intake of each individual heterocyclic amine (i.e., MeIQx, PhIP, and DiMeIQx) and MDM by multiplying the frequency of cooked meat intake from the 1996 cooking questionnaire with measured individual heterocyclic amine (ng/g meat) or MDM levels (revertant colonies/g meat) and standard (medium) portion size from the Charred Database. We also examined associations between the predicted heterocyclic amine mutagenicity (PHM; i.e., the mutagenicity that can be attributed to all measured heterocyclic amines) and adenoma. PHM was calculated by multiplying the amount of heterocyclic amines measured in the sample and multiplying them with the mutagenic capacity for that compound and then summing up the mutagenicity for all heterocyclic amines (http://www.charred.cancer.gov).

Because the cooking questionnaire did not assess frequency of consumption of specific meats (i.e., total meat intake regardless of cooking method), we computed total intake of specific meats using information from the 1986 to 1994 FFQs (cumulative average intake, see above). Among the study participants, the vast majority (88%) completed all questions on frequency of intake of meat prepared with different cooking methods. For missing data among participants who had reported frequency of intake but left the doneness section blank, we imputed the mode for doneness (lightly brown for broiled fish and medium browned for all other meat items). For participants who had reported nonzero intake of chicken but did not report whether the chicken was cooked or eaten with skin, we assumed that they did not cook or eat chicken skin, because the majority of participants who had reported nonzero intake of chicken did not cook (51%) or eat chicken skin (76%).

Statistical Analysis

We used multivariable logistic regression models and calculated odds ratios (OR) to assess associations between dietary variables and adenoma risk. We included known and suspected risk factors for colorectal adenoma in our final models (shown in footnotes in tables). All dietary variables, age, physical activity, and smoking status, were updated up to the 1998 questionnaire or the year of the questionnaire before the most recent endoscopy (for cases, this would be the endoscopy that led to the diagnosis of adenoma; for controls, this would be the year of the most recent reported endoscopy), whichever came first. In addition, we assessed possible confounding from other dietary factors by adding each other dietary factor separately to the final multivariable models. We computed trend tests by adding a continuous variable using the median for each quintile of the exposure (i.e., heterocyclic amine, MDM, and meat intake) to the multivariable models.

Table 1 shows the baseline characteristics in the HPFS by quintiles of heterocyclic amine intake and MDM. Participants in the highest quintile of PhIP, MeIQx, and DiMeIQx intake and MDM had a slightly higher number of pack-years of smoking and were more likely to be current smokers compared with those in the lowest quintile of intake. In addition, participants in the highest quintile of MeIQx intake seemed to be less physically active than those in the lowest quintile. Higher intake of heterocyclic amine and higher MDM were associated with higher intake of total energy and certain nutrients, including total fat, animal protein, heme iron, and alcohol, but with lower intake of total iron, vitamin C, total carotene, vitamin D, calcium, and fiber.

Table 1.

Baseline characteristics in the HPFS study population by lowest and highest quintiles of heterocyclic amine and MDM intake

PhIP (ng/d)
MeIQx (ng/d)
DiMeIQx (ng/d)
MDM (revertant colonies/d)
Q1 (14.4)Q5 (220.4)Q1 (1.5)Q5 (35.0)Q1 (0)Q5 (4.0)Q1 (711)Q5 (8,125)
Mean age (y) 65.0 59.7 63.6 62.3 64.0 60.1 64.2 60.9 
Race (%)*         
    Southern European 19.4 21.7 22.4 18.0 22.2 21.0 21.5 19.9 
    Northern European 70.2 67.3 65.7 71.8 67.4 69.7 67.4 70.1 
    Others 3.8 5.0 4.5 3.6 4.0 3.4 4.3 4.1 
Current smokers (%) 3.0 4.7 1.3 6.7 2.7 4.9 2.1 5.4 
Mean pack-years smoking 9.8 12.6 9.2 13.6 10.6 12.0 9.7 12.7 
Family history of colorectal cancer (%) 17.2 17.1 17.5 16.6 16.5 15.9 16.9 16.4 
Aspirin use (>2/wk; %) 52.8 55.3 55.3 54.8 54.7 57.2 53.9 56.9 
Mean height (inches) 70.1 70.2 69.9 70.5 70.1 70.3 70.0 70.3 
Body mass index (kg/m225.0 25.9 24.8 26.1 25.4 25.8 25.0 25.9 
Physical activity (MET) 34.7 34.5 36.7 32.4 34.4 34.7 34.6 33.7 
Mean daily intake (94 FFQ)         
    Calories (kcal) 1,864 2,128 1,796 2,265 1,910 2,108 1,827 2,173 
    Total fat (g) 60.2 67.4 56.0 72.6 62.3 65.8 60.1 67.1 
    Animal protein (g) 54.3 63.8 54.9 62.9 58.9 62.1 53.9 63.6 
    Vegetable protein (g) 30.0 26.2 31.2 87.8 28.5 27.0 30.1 26.4 
    Total iron (mg) 22.5 20.0 22.6 19.5 21.9 20.3 22.2 20.4 
    Heme iron (mg) 0.9 1.3 0.9 1.3 1.1 1.2 0.92 1.3 
    Folate (μg) 583 529 612 485 567 527 584 525 
    Methionine (g) 1.9 2.1 2.0 2.1 2.0 2.1 1.9 2.1 
    Alcohol (g) 9.1 13.8 8.7 12.7 10.5 12.3 9.5 12.4 
    Vitamin C (mg) 565 465 613 392 528 452 568 445 
    Total carotene (IU) 15,027 12,463 16,488 10,794 14,279 12,646 15,054 12,282 
    Vitamin D (IU) 493 444 522 407 488 436 498 440 
    Calcium (mg) 1,012 860 1,013 867 967 896 995 884 
    Total fiber (g) 25.8 21.9 27.4 20.3 24.4 22.5 25.8 22.0 
    Red meat (servings/d) 0.35 0.65 0.24 0.84 0.43 0.62 0.31 0.69 
    Processed meat (servings/d) 0.17 0.31 0.10 0.46 0.21 0.28 0.15 0.34 
    Chicken + turkey (servings/d) 0.33 0.48 0.38 0.39 0.39 0.44 0.33 0.47 
PhIP (ng/d)
MeIQx (ng/d)
DiMeIQx (ng/d)
MDM (revertant colonies/d)
Q1 (14.4)Q5 (220.4)Q1 (1.5)Q5 (35.0)Q1 (0)Q5 (4.0)Q1 (711)Q5 (8,125)
Mean age (y) 65.0 59.7 63.6 62.3 64.0 60.1 64.2 60.9 
Race (%)*         
    Southern European 19.4 21.7 22.4 18.0 22.2 21.0 21.5 19.9 
    Northern European 70.2 67.3 65.7 71.8 67.4 69.7 67.4 70.1 
    Others 3.8 5.0 4.5 3.6 4.0 3.4 4.3 4.1 
Current smokers (%) 3.0 4.7 1.3 6.7 2.7 4.9 2.1 5.4 
Mean pack-years smoking 9.8 12.6 9.2 13.6 10.6 12.0 9.7 12.7 
Family history of colorectal cancer (%) 17.2 17.1 17.5 16.6 16.5 15.9 16.9 16.4 
Aspirin use (>2/wk; %) 52.8 55.3 55.3 54.8 54.7 57.2 53.9 56.9 
Mean height (inches) 70.1 70.2 69.9 70.5 70.1 70.3 70.0 70.3 
Body mass index (kg/m225.0 25.9 24.8 26.1 25.4 25.8 25.0 25.9 
Physical activity (MET) 34.7 34.5 36.7 32.4 34.4 34.7 34.6 33.7 
Mean daily intake (94 FFQ)         
    Calories (kcal) 1,864 2,128 1,796 2,265 1,910 2,108 1,827 2,173 
    Total fat (g) 60.2 67.4 56.0 72.6 62.3 65.8 60.1 67.1 
    Animal protein (g) 54.3 63.8 54.9 62.9 58.9 62.1 53.9 63.6 
    Vegetable protein (g) 30.0 26.2 31.2 87.8 28.5 27.0 30.1 26.4 
    Total iron (mg) 22.5 20.0 22.6 19.5 21.9 20.3 22.2 20.4 
    Heme iron (mg) 0.9 1.3 0.9 1.3 1.1 1.2 0.92 1.3 
    Folate (μg) 583 529 612 485 567 527 584 525 
    Methionine (g) 1.9 2.1 2.0 2.1 2.0 2.1 1.9 2.1 
    Alcohol (g) 9.1 13.8 8.7 12.7 10.5 12.3 9.5 12.4 
    Vitamin C (mg) 565 465 613 392 528 452 568 445 
    Total carotene (IU) 15,027 12,463 16,488 10,794 14,279 12,646 15,054 12,282 
    Vitamin D (IU) 493 444 522 407 488 436 498 440 
    Calcium (mg) 1,012 860 1,013 867 967 896 995 884 
    Total fiber (g) 25.8 21.9 27.4 20.3 24.4 22.5 25.8 22.0 
    Red meat (servings/d) 0.35 0.65 0.24 0.84 0.43 0.62 0.31 0.69 
    Processed meat (servings/d) 0.17 0.31 0.10 0.46 0.21 0.28 0.15 0.34 
    Chicken + turkey (servings/d) 0.33 0.48 0.38 0.39 0.39 0.44 0.33 0.47 

NOTE: Standardized for age in 1996. Q1 is lowest quintile and Q5 is highest quintile. Numbers in parentheses are median value in each quintile (ng/d for heterocyclic amines and revertant colonies/d for MDM).

Abbreviation: MET, metabolic equivalent-hours/wk.

*

Due to missing values, percentages for race do not add up to 100%.

Mean daily intakes of nutrients are energy adjusted.

Intakes of MeIQx, PhIP, and DiMeIQx were moderately correlated with each other (MeIQx versus PhIP: r = 0.54, MeIQx versus DiMeIQx: r = 0.45, PhIP versus DiMeIQx: r = 0.47). Heterocyclic amines and MDM were also correlated (DiMeIQx versus MDM: r = 0.41, PhIP versus MDM: r = 0.68, MeIQx versus MDM: r = 0.70). Table 2 shows mean intake and percentage contribution of heterocyclic amine intake and MDM by meats prepared with different cooking methods. Grilled chicken, grilled steak, and broiled chicken contributed most to total PhIP intake, whereas pan-fried hamburgers and grilled steak contributed most to total MeIQx intake. The most important contributors to total DiMeIQx intake were grilled chicken and pan-fried hamburgers. Broiled chicken, grilled chicken, and pan-fried hamburgers contributed most to MDM.

Table 2.

Mean intake of heterocyclic amine and MDM by meat type, HPFS

PhIP
MeIQx
DiMeIQx
MDM
Mean (SD), ng/d%Mean (SD), ng/d%Mean (SD), ng/d%Mean (SD), revertant colonies/d%
All sources 103 (110)  15.4 (18.0)  1.4 (2.4)  3,718 (3,272)  
Pan-fried chicken 8.9 (23.9) 8.6 1.05 (2.3) 6.8 0.05 (0.21) 3.6 457 (1,047) 12.3 
Broiled chicken 23.6 (44.2) 22.9 0.38 (0.88) 2.5 0.01 (0.17) 0.7 982 (1,695) 26.4 
Grilled chicken 43.5 (71.2) 42.2 1.2 (2.5) 7.8 0.88 (2.2) 62.9 850 (1,277) 22.9 
Pan-fried hamburger 0.06 (1.5) 0.1 6.5 (12.3) 42.2 0.32 (0.72) 22.9 647 (1,274) 17.4 
Grilled steak 25.9 (45.7) 25.1 3.2 (4.9) 20.8 N/A 535 (1,120) 14.4 
Fried bacon 0.76 (1.7) 0.7 1.8 (4.2) 11.7 N/A 110 (251) 3.0 
Homemade beef gravy 0.43 (2.7) 0.4 1.3 (4.7) 8.4 0.11 (0.71) 7.9 136 (538) 3.7 
PhIP
MeIQx
DiMeIQx
MDM
Mean (SD), ng/d%Mean (SD), ng/d%Mean (SD), ng/d%Mean (SD), revertant colonies/d%
All sources 103 (110)  15.4 (18.0)  1.4 (2.4)  3,718 (3,272)  
Pan-fried chicken 8.9 (23.9) 8.6 1.05 (2.3) 6.8 0.05 (0.21) 3.6 457 (1,047) 12.3 
Broiled chicken 23.6 (44.2) 22.9 0.38 (0.88) 2.5 0.01 (0.17) 0.7 982 (1,695) 26.4 
Grilled chicken 43.5 (71.2) 42.2 1.2 (2.5) 7.8 0.88 (2.2) 62.9 850 (1,277) 22.9 
Pan-fried hamburger 0.06 (1.5) 0.1 6.5 (12.3) 42.2 0.32 (0.72) 22.9 647 (1,274) 17.4 
Grilled steak 25.9 (45.7) 25.1 3.2 (4.9) 20.8 N/A 535 (1,120) 14.4 
Fried bacon 0.76 (1.7) 0.7 1.8 (4.2) 11.7 N/A 110 (251) 3.0 
Homemade beef gravy 0.43 (2.7) 0.4 1.3 (4.7) 8.4 0.11 (0.71) 7.9 136 (538) 3.7 

Table 3 shows the ORs and 95% confidence intervals (95% CI) of distal adenoma by quintiles of heterocyclic amine intake and MDM before and after adjusting for cumulative average total red meat and processed meat intake. Higher intake of MDM was marginally associated with increased risk of adenoma. Adjusting for total red meat or processed meat intake attenuated associations only slightly. Our data also suggested a positive association between higher MeIQx and risk of adenoma, but this association was attenuated after adjusting for processed meat intake. DiMeIQx and PhIP did not seem to be associated with risk of adenoma.

Table 3.

ORs (95% CIs) of distal colon adenoma by quintiles of heterocyclic amine and MDM intake before and after adjusting for red and processed meat intake, HPFS

Heterocyclic amine intake (ng/d)/mutagenicity (revertant colonies/d)
Ptrend
1 (Low)2345
Total MeIQx intake (ng/d), median 1.5 5.3 9.9 17.3 35.0  
    Cases/controls 88/2,720 113/2,693 119/2,688 124/2,681 137/2,669  
    Multivariable* 1.00 1.18 (0.88-1.57) 1.22 (0.91-1.63) 1.19 (0.89-1.59) 1.28 (0.95-1.71) 0.22 
    Multivariable (+red meat) 1.00 1.15 (0.86-1.54) 1.17 (0.87-1.58) 1.15 (0.84-1.56) 1.23 (0.90-1.68) 0.34 
    Multivariable (+processed meat) 1.00 1.12 (0.84-1.50) 1.13 (0.84-1.52) 1.08 (0.80-1.46) 1.14 (0.83-1.55) 0.66 
Total PhIP intake (ng/d), median 14.4 39.1 70.6 117.4 220.4  
    Cases/controls 108/2,696 110/2,700 108/2,699 122/2,683 133/2,673  
    Multivariable* 1.00 0.97 (0.74-1.28) 0.93 (0.71-1.23) 1.05 (0.80-1.38) 1.11 (0.85-1.46) 0.25 
    Multivariable (+red meat) 1.00 0.95 (0.72-1.26) 0.91 (0.69-1.20) 1.03 (0.78-1.35) 1.09 (0.83-1.44) 0.29 
    Multivariable (+processed meat) 1.00 0.95 (0.72-1.25) 0.89 (0.68-1.18) 1.01 (0.77-1.33) 1.08 (0.82-1.42) 0.32 
Total DiMeIQx intake (ng/d), median 0.2 0.5 1.2 4.0  
    Cases/controls 183/4,372 39/1,266 95/2,222 129/2,873 135/2,718  
    Multivariable* 1.00 0.72 (0.51-1.03) 0.97 (0.75-1.25) 0.99 (0.79-1.26) 1.08 (0.86-1.37) 0.22 
    Multivariable (+red meat) 1.00 0.71 (0.50-1.02) 0.96 (0.74-1.24) 0.97 (0.77-1.23) 1.07 (0.85-1.36) 0.25 
    Multivariable (+processed meat) 1.00 0.70 (0.49-1.00) 0.94 (0.73-1.22) 0.96 (0.75-1.21) 1.06 (0.84-1.35) 0.25 
MDM (revertant colonies/d), median 711 1,736 2,831 4,347 8,125  
    Cases/controls 90/2,718 100/2,705 127/2,676 135/2,672 129/2,680  
    Multivariable* 1.00 1.05 (0.78-1.41) 1.32 (1.00-1.75) 1.39 (1.05-1.84) 1.29 (0.97-1.72) 0.08 
    Multivariable (+red meat) 1.00 1.03 (0.77-1.39) 1.30 (0.98-1.73) 1.36 (1.03-1.81) 1.26 (0.94-1.69) 0.10 
    Multivariable (+processed meat) 1.00 1.02 (0.76-1.37) 1.27 (0.96-1.69) 1.33 (1.00-1.77) 1.23 (0.92-1.65) 0.13 
Heterocyclic amine intake (ng/d)/mutagenicity (revertant colonies/d)
Ptrend
1 (Low)2345
Total MeIQx intake (ng/d), median 1.5 5.3 9.9 17.3 35.0  
    Cases/controls 88/2,720 113/2,693 119/2,688 124/2,681 137/2,669  
    Multivariable* 1.00 1.18 (0.88-1.57) 1.22 (0.91-1.63) 1.19 (0.89-1.59) 1.28 (0.95-1.71) 0.22 
    Multivariable (+red meat) 1.00 1.15 (0.86-1.54) 1.17 (0.87-1.58) 1.15 (0.84-1.56) 1.23 (0.90-1.68) 0.34 
    Multivariable (+processed meat) 1.00 1.12 (0.84-1.50) 1.13 (0.84-1.52) 1.08 (0.80-1.46) 1.14 (0.83-1.55) 0.66 
Total PhIP intake (ng/d), median 14.4 39.1 70.6 117.4 220.4  
    Cases/controls 108/2,696 110/2,700 108/2,699 122/2,683 133/2,673  
    Multivariable* 1.00 0.97 (0.74-1.28) 0.93 (0.71-1.23) 1.05 (0.80-1.38) 1.11 (0.85-1.46) 0.25 
    Multivariable (+red meat) 1.00 0.95 (0.72-1.26) 0.91 (0.69-1.20) 1.03 (0.78-1.35) 1.09 (0.83-1.44) 0.29 
    Multivariable (+processed meat) 1.00 0.95 (0.72-1.25) 0.89 (0.68-1.18) 1.01 (0.77-1.33) 1.08 (0.82-1.42) 0.32 
Total DiMeIQx intake (ng/d), median 0.2 0.5 1.2 4.0  
    Cases/controls 183/4,372 39/1,266 95/2,222 129/2,873 135/2,718  
    Multivariable* 1.00 0.72 (0.51-1.03) 0.97 (0.75-1.25) 0.99 (0.79-1.26) 1.08 (0.86-1.37) 0.22 
    Multivariable (+red meat) 1.00 0.71 (0.50-1.02) 0.96 (0.74-1.24) 0.97 (0.77-1.23) 1.07 (0.85-1.36) 0.25 
    Multivariable (+processed meat) 1.00 0.70 (0.49-1.00) 0.94 (0.73-1.22) 0.96 (0.75-1.21) 1.06 (0.84-1.35) 0.25 
MDM (revertant colonies/d), median 711 1,736 2,831 4,347 8,125  
    Cases/controls 90/2,718 100/2,705 127/2,676 135/2,672 129/2,680  
    Multivariable* 1.00 1.05 (0.78-1.41) 1.32 (1.00-1.75) 1.39 (1.05-1.84) 1.29 (0.97-1.72) 0.08 
    Multivariable (+red meat) 1.00 1.03 (0.77-1.39) 1.30 (0.98-1.73) 1.36 (1.03-1.81) 1.26 (0.94-1.69) 0.10 
    Multivariable (+processed meat) 1.00 1.02 (0.76-1.37) 1.27 (0.96-1.69) 1.33 (1.00-1.77) 1.23 (0.92-1.65) 0.13 
*

Models adjusted for age (in 5-year categories), family history of colorectal cancer (first-degree relative), reason for endoscopy (screening versus others), negative endoscopy before 1996 (yes versus no), physical activity (metabolic equivalent-hours/wk in quintiles), smoking status (never smokers, past smokers who quit ≤10 years ago, past smokers who quit >10 years ago, current smokers), race, aspirin use (<2/wk versus ≥2/wk), total energy intake (in quintiles), and calcium and folate intake (in quintiles).

We investigated associations between cumulative average meat intake regardless of cooking method and risk of adenoma before and after adjusting for MeIQx and MDM intake (Table 4). We found a positive association between higher intake of processed meat [defined as the sum of the following meat items on the FFQs: processed meats (sausage, salami, bologna, etc.), bacon, and hotdogs] and risk of adenoma. Chicken and turkey intake was not associated with adenoma risk.

Table 4.

ORs (95% CIs) of distal colon adenoma by quintiles of meat intake before and after adjusting for MDM and MeIQx, HPFS

Categories of meat intake
Ptrend
1 (Low)2345
Total red meat (servings/wk), median 1.1 2.3 3.4 4.8 7.2  
    Cases/controls 96/3,006 97/2,285 128/2,779 124/2,702 136/2,679  
    Multivariable* 1.00 1.16 (0.86-1.55) 1.24 (0.93-1.64) 1.19 (0.88-1.59) 1.18 (0.87-1.62) 0.43 
    Multivariable (+MDM) 1.00 1.12 (0.84-1.51) 1.19 (0.89-1.58) 1.12 (0.83-1.51) 1.10 (0.80-1.52) 0.75 
    Multivariable (+MeIQx) 1.00 1.12 (0.83-1.51) 1.17 (0.88-1.58) 1.11 (0.81-1.52) 1.10 (0.79-1.54) 0.79 
Hamburger (servings/wk), median 0.16 0.65 0.82 1.5 2.5  
    Cases/controls 82/2,457 113/3,099 120/2,640 134/2,782 132/2,473  
    Multivariable* 1.00 0.97 (0.72-1.30) 1.19 (0.88-1.60) 1.22 (0.91-1.64) 1.24 (0.91-1.70) 0.10 
    Multivariable (+MDM) 1.00 0.94 (0.70-1.27) 1.14 (0.85-1.54) 1.16 (0.86-1.57) 1.17 (0.85-1.61) 0.22 
    Multivariable (+MeIQx) 1.00 0.94 (0.69-1.26) 1.13 (0.83-1.54) 1.16 (0.85-1.59) 1.17 (0.84-1.64) 0.22 
Beef, lamb, and pork as main dish (servings/wk), median 0.33 0.82 1.3 2.1 3.3  
    Cases/controls 80/2,551 130/2,911 129/2,901 112/2,590 130/2,498  
    Multivariable* 1.00 1.28 (0.96-1.71) 1.20 (0.89-1.61) 1.12 (0.82-1.53) 1.26 (0.92-1.74) 0.49 
    Multivariable (+MDM) 1.00 1.23 (0.92-1.65) 1.14 (0.85-1.54) 1.06 (0.77-1.45) 1.17 (0.85-1.62) 0.81 
    Multivariable (+MeIQx) 1.00 1.23 (0.91-1.65) 1.14 (0.84-1.55) 1.05 (0.76-1.46) 1.18 (0.84-1/65) 0.81 
Processed meat (servings/wk), median 0.16 0.65 1.3 2.4 4.5  
    Cases/controls 77/2,681 88/2,275 140/3,115 126/2,716 150/2,664  
    Multivariable* 1.00 1.22 (0.89-1.70) 1.34 (1.00-1.80) 1.36 (1.00-1.84) 1.52 (1.12-2.08) 0.02 
    Multivariable (+MDM) 1.00 1.20 (0.87-1.65) 1.30 (0.97-1.74) 1.31 (0.96-1.78) 1.46 (1.06-1.99) 0.04 
    Multivariable (+MeIQx) 1.00 1.20 (0.87-1.64) 1.30 (0.96-1.76) 1.31 (0.96-1.80) 1.47 (1.06-2.04) 0.05 
Chicken + turkey (servings/wk), median 0.98 1.8 2.5 3.2 4.5  
    Cases/controls 137/2,895 104/2,423 132/2,737 104/2,757 104/2,639  
    Multivariable* 1.00 0.94 (0.72-1.23) 1.12 (0.87-1.44) 0.88 (0.67-1.15) 0.90 (0.69-1.19) 0.38 
    Multivariable (+MDM) 1.00 0.93 (0.71-1.21) 1.09 (0.85-1.41) 0.85 (0.65-1.11) 0.87 (0.66-1.15) 0.26 
    Multivariable (+MeIQx) 1.00 0.94 (0.72-1.23) 1.13 (0.88-1.45) 0.89 (0.68-1.16) 0.92 (0.70-1.21) 0.46 
Categories of meat intake
Ptrend
1 (Low)2345
Total red meat (servings/wk), median 1.1 2.3 3.4 4.8 7.2  
    Cases/controls 96/3,006 97/2,285 128/2,779 124/2,702 136/2,679  
    Multivariable* 1.00 1.16 (0.86-1.55) 1.24 (0.93-1.64) 1.19 (0.88-1.59) 1.18 (0.87-1.62) 0.43 
    Multivariable (+MDM) 1.00 1.12 (0.84-1.51) 1.19 (0.89-1.58) 1.12 (0.83-1.51) 1.10 (0.80-1.52) 0.75 
    Multivariable (+MeIQx) 1.00 1.12 (0.83-1.51) 1.17 (0.88-1.58) 1.11 (0.81-1.52) 1.10 (0.79-1.54) 0.79 
Hamburger (servings/wk), median 0.16 0.65 0.82 1.5 2.5  
    Cases/controls 82/2,457 113/3,099 120/2,640 134/2,782 132/2,473  
    Multivariable* 1.00 0.97 (0.72-1.30) 1.19 (0.88-1.60) 1.22 (0.91-1.64) 1.24 (0.91-1.70) 0.10 
    Multivariable (+MDM) 1.00 0.94 (0.70-1.27) 1.14 (0.85-1.54) 1.16 (0.86-1.57) 1.17 (0.85-1.61) 0.22 
    Multivariable (+MeIQx) 1.00 0.94 (0.69-1.26) 1.13 (0.83-1.54) 1.16 (0.85-1.59) 1.17 (0.84-1.64) 0.22 
Beef, lamb, and pork as main dish (servings/wk), median 0.33 0.82 1.3 2.1 3.3  
    Cases/controls 80/2,551 130/2,911 129/2,901 112/2,590 130/2,498  
    Multivariable* 1.00 1.28 (0.96-1.71) 1.20 (0.89-1.61) 1.12 (0.82-1.53) 1.26 (0.92-1.74) 0.49 
    Multivariable (+MDM) 1.00 1.23 (0.92-1.65) 1.14 (0.85-1.54) 1.06 (0.77-1.45) 1.17 (0.85-1.62) 0.81 
    Multivariable (+MeIQx) 1.00 1.23 (0.91-1.65) 1.14 (0.84-1.55) 1.05 (0.76-1.46) 1.18 (0.84-1/65) 0.81 
Processed meat (servings/wk), median 0.16 0.65 1.3 2.4 4.5  
    Cases/controls 77/2,681 88/2,275 140/3,115 126/2,716 150/2,664  
    Multivariable* 1.00 1.22 (0.89-1.70) 1.34 (1.00-1.80) 1.36 (1.00-1.84) 1.52 (1.12-2.08) 0.02 
    Multivariable (+MDM) 1.00 1.20 (0.87-1.65) 1.30 (0.97-1.74) 1.31 (0.96-1.78) 1.46 (1.06-1.99) 0.04 
    Multivariable (+MeIQx) 1.00 1.20 (0.87-1.64) 1.30 (0.96-1.76) 1.31 (0.96-1.80) 1.47 (1.06-2.04) 0.05 
Chicken + turkey (servings/wk), median 0.98 1.8 2.5 3.2 4.5  
    Cases/controls 137/2,895 104/2,423 132/2,737 104/2,757 104/2,639  
    Multivariable* 1.00 0.94 (0.72-1.23) 1.12 (0.87-1.44) 0.88 (0.67-1.15) 0.90 (0.69-1.19) 0.38 
    Multivariable (+MDM) 1.00 0.93 (0.71-1.21) 1.09 (0.85-1.41) 0.85 (0.65-1.11) 0.87 (0.66-1.15) 0.26 
    Multivariable (+MeIQx) 1.00 0.94 (0.72-1.23) 1.13 (0.88-1.45) 0.89 (0.68-1.16) 0.92 (0.70-1.21) 0.46 
*

Models adjusted for age (in 5-year categories), family history of colorectal cancer (first-degree relative), reason for endoscopy (screening versus others), negative endoscopy before 1996 (yes versus no), physical activity (metabolic equivalent-hours/wk in quintiles), smoking status (never smokers, past smokers who quit ≤10 years ago, past smokers who quit >10 years ago, current smokers), race, aspirin use (<2/wk versus ≥2/wk), total energy intake (in quintiles), and calcium and folate intake (in quintiles).

When MDM and all three heterocyclic amines were modeled simultaneously in one model, positive associations between MDM and adenoma were not altered appreciably (fourth versus lowest quintile: OR, 1.50; 95% CI, 1.04-2.16; highest versus lowest quintile: OR, 1.37; 95% CI, 0.92-2.05) and no associations between any of the three heterocyclic amines and adenoma were found.

We also examined whether the observed associations between MDM and adenoma could be explained by the PHM (for information on how PHM was calculated, see Materials and Methods). PHM was moderately correlated with MDM (r = 0.73), PhIP (r = 0.62), and DiMeIQx (r = 0.58) but was almost perfectly correlated with MeIQx (r = 0.96). PHM itself was associated with increased risk of adenoma (highest versus lowest quintile: multivariable OR, 1.30; 95% CI, 1.01-1.69; Ptrend = 0.08). However, when we included both MDM and PHM in one model, there was no association between PHM and risk of adenoma and associations between MDM and adenoma were attenuated but remained similar (fourth versus lowest quintile: PHM, OR, 0.97; 95% CI, 0.68-1.37; MDM, OR, 1.38; 95% CI, 0.98-1.94; highest versus lowest quintile: PHM, OR, 1.09; 95% CI, 0.75-1.58; MDM, OR, 1.26; 95% CI, 0.87-1.82).

Adding intakes of total fat, animal protein, total iron, heme iron, vitamin C, vitamin D, total fiber, and total carotene as well as multivitamin and vitamin E supplementation separately to the models attenuated associations between heterocyclic amines and MDM and adenoma slightly, but results remained similar (data not shown).

Because large adenomas may have a higher probability than small adenomas to develop into colon cancers (6), we also investigated associations for small (<1 cm) and large (≥1 cm) adenomas separately. Risk factors that are involved in the initial formation of an adenoma may differ from those factors that cause progression of an adenoma (6, 27). Therefore, we restricted participants with small adenoma to those with negative endoscopies before 1996 to examine associations between incident small adenoma and meat mutagens. Participants with large adenoma were restricted to those without a negative endoscopy before 1996. Red meat was borderline positively associated with large adenoma (highest versus lowest quintile: OR, 1.95; 95% CI, 0.97-3.91; Ptrend = 0.05) but not with risk of small incident adenoma (highest versus lowest quintile: OR, 0.96; 95% CI, 0.54-1.72; Ptrend = 0.70). Processed meat intake also seemed to be associated with large adenoma, but all 95% CIs included one. Results for the three heterocyclic amines and MDM did not seem to differ considerably by adenoma size (data not shown).

In this large prospective study, higher intake of MDM was marginally associated with increased risk of adenoma. Adjusting for total red meat or processed meat intake did not explain those associations.

Heterocyclic amines are mutagenic in animal and in vitro studies and are carcinogenic in animal studies (5). PhIP, the most abundant heterocyclic amine in cooked meats, is a weak mutagen, whereas MeIQx and particularly DiMeIQx are more potent mutagens (28). Therefore, we believe that summing up the individual heterocyclic amines may not be advisable because no consideration is given to the fact that individual heterocyclic amines differ with regard to mutagenic and carcinogenic potential and more weight is given to the one that is the most abundant in cooked meat (i.e., PhIP; ref. 15). MDM, on the other hand, is a measure of the total mutagenic activity found in cooked meats (http://www.charred.cancer.gov). Moreover, MDM integrates mutagenic activity from heterocyclic amines and from other yet unidentified compounds found in cooked meats (15). We therefore believe that MDM in cooked meats may be a better measure to assess a possible overall effect of cooking methods on disease risk in epidemiologic studies than measuring total heterocyclic amine in cooked meats (15).

When we included both MDM and PHM in one model, positive associations between MDM and adenoma were attenuated but remained similar. These results suggest that mutagens other than heterocyclic amines may also play a role in explaining the observed associations between MDM and adenoma. Given the collinearity between these two measures, we could not examine this hypothesis in more detail.

Epidemiologic data on the association between heterocyclic amine intake (8, 15-17) and MDM (8, 15) and risk of colorectal cancers or adenomas are sparse, and to our knowledge, no prospective data are available. In a Swedish population-based case-control study (17) with 352 colon cancer and 249 rectal cancer cases, no evidence for a positive association between higher intake of PhIP, MeIQx, and DiMeIQx and total heterocyclic amine and risk of colon or rectal cancer was observed. In fact, controls seemed to have somewhat higher total heterocyclic amine intake than cases. However, four colon cancer cases but none of the controls had heterocyclic amine intakes above 1,900 ng/d, suggesting the possibility of an increased risk at the very high end of heterocyclic amine intake (17). In addition, MDM was not assessed in that study. The Swedish heterocyclic amine database is not directly comparable with the Charred database (http://www.charred.cancer.gov) because meats were cooked to different level of doneness (29).

In contrast, in a case-control study from the United States, participants in the highest compared with the lowest quartile of MeIQx intake had an ∼4-fold increased risk of developing colorectal cancers (Ptrend < 0.05; ref. 16). In another U.S. case-control study, higher DiMeIQx intake was associated with significantly higher risk of colon cancer and higher MDM was weakly associated with higher risk (8). In the case-control study that examined the association between heterocyclic amine intake and MDM and risk of colorectal adenoma (15), positive associations between higher intake of heterocyclic amines and risk of colorectal adenoma were seen for DiMeIQx, PhIP, and MDM. After adjusting for red meat, positive associations remained statistically significant for MeIQx and MDM. However, positive associations between red meat intake and adenoma disappeared after adding either heterocyclic amine or MDM to the models (15).

For case-control studies that assess exposure after diagnosis, recall bias cannot be excluded. Therefore, the prospective design can be considered as one of the strengths of this study. All exposure data used in this analysis were collected before diagnosis of the colon adenoma and should not have been biased by the outcome. Another strength is the use of several FFQs, which enhanced our estimate of long-term dietary intake (22). Our detailed FFQs also enabled us to examine possible confounding with several nutrients and dietary factors.

However, our study also has limitations. Heterocyclic amine and MDM intake were based on a limited set of cooking method questions; however, the cooking method questions included in the 1996 questionnaire were based on the results of a detailed pilot study, which determined the group of cooking method questions that would best predict heterocyclic amine intake in this specific cohort (26). Secondly, we cannot exclude the possibility of misclassification of exposure to heterocyclic amine due to certain factors, such as frequency of flipping the meat during the cooking process or meat thickness, which were not captured in this questionnaire. Thirdly, information on cooking methods were only obtained in 1996, so repeated measurements were not available. Finally, the heterocyclic amines are not carcinogenic by themselves but need to be metabolized by activity enzymes, such as cytochrome P450 1A2, N-acetyltransferase 1, N-acetyltransferase 2, and sulfotransferases (30-33). Epidemiologic studies that have investigated possible interactions between genetic polymorphisms of some of these metabolic enzymes and cooking methods of meats in relation to risk of colorectal cancer have yielded inconsistent results (9). We did not study interactions between heterocyclic amine intake and genetic polymorphisms of metabolic enzymes here.

In conclusion, higher consumption of mutagens from meats cooked at higher temperature and longer duration may be associated with higher risk of distal colon adenoma independent of overall meat intake. Because mutagens other than heterocyclic amines also contribute to MDM, our results suggest that mutagens other than heterocyclic amines in cooked meats may also play a role in increasing the risk of distal adenoma.

Grant support: National Cancer Institute, NIH grants CA 55075 and CA95589.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1
Norat T, Lukanova A, Ferrari P, Riboli E. Meat consumption and colorectal cancer risk: dose-response meta-analysis of epidemiological studies.
Int J Cancer
2002
;
98
:
241
–56.
2
Norat T, Riboli E. Meat consumption and colorectal cancer: a review of epidemiologic evidence.
Nutr Rev
2001
;
59
:
37
–47.
3
Sandhu MS, White IR, McPherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach.
Cancer Epidemiol Biomarkers Prev
2001
;
10
:
439
–46.
4
Yoon H, Benamouzig R, Little J, Francois-Collange M, Tome D. Systematic review of epidemiological studies on meat, dairy products and egg consumption and risk of colorectal adenomas.
Eur J Cancer Prev
2000
;
9
:
151
–64.
5
Sinha R, Rothman N. Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies.
Mutat Res
1997
;
376
:
195
–202.
6
Cotton S, Sharp L, Little J. The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia.
Crit Rev Oncog
1996
;
7
:
293
–342.
7
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis.
Cell
1990
;
61
:
759
–67.
8
Butler LM, Sinha R, Millikan RC, et al. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study.
Am J Epidemiol
2003
;
157
:
434
–45.
9
Cross AJ, Sinha R. Meat-related mutagens/carcinogens in the etiology of colorectal cancer.
Environ Mol Mutagen
2004
;
44
:
44
–55.
10
Sinha R, Rothman N, Salmon CP, et al. Heterocyclic amine content in beef cooked by different methods to varying degrees of doneness and gravy made from meat drippings.
Food Chem Toxicol
1998
;
36
:
279
–87.
11
Sinha R, Knize MG, Salmon CP, et al. Heterocyclic amine content of pork products cooked by different methods and to varying degrees of doneness.
Food Chem Toxicol
1998
;
36
:
289
–97.
12
Sinha R, Rothman N, Brown ED, et al. High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method.
Cancer Res
1995
;
55
:
4516
–9.
13
Sinha R. An epidemiologic approach to studying heterocyclic amines.
Mutat Res
2002
;
506–507
:
197
–204.
14
Ames BN, McCann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.
Mutat Res
1975
;
31
:
347
–64.
15
Sinha R, Kulldorff M, Chow WH, Denobile J, Rothman N. Dietary intake of heterocyclic amines, meat-derived mutagenic activity, and risk of colorectal adenomas.
Cancer Epidemiol Biomarkers Prev
2001
;
10
:
559
–62.
16
Nowell S, Coles B, Sinha R, et al. Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colorectal cancer: contribution of metabolic variation to risk.
Mutat Res
2002
;
506–507
:
175
–85.
17
Augustsson K, Skog K, Jagerstad M, Dickman PW, Steineck G. Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study.
Lancet
1999
;
353
:
703
–7.
18
Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men [see comments].
Lancet
1991
;
338
:
464
–8.
19
Wei EK, Giovannucci E, Wu K, et al. Comparison of risk factors for colon and rectal cancer.
Int J Cancer
2004
;
108
:
433
–42.
20
Gross GA, Gruter A. Quantitation of mutagenic/carcinogenic heterocyclic aromatic amines in food products.
J Chromatogr
1992
;
592
:
271
–8.
21
Knize MG, Sinha R, Rothman N, et al. Heterocyclic amine content in fast-food meat products.
Food Chem Toxicol
1995
;
33
:
545
–51.
22
Willett WC. Issues in analysis and presentation of dietary data. In: Willett WC, editor. Nutritional epidemiology. New York: Oxford University Press; 1998. pp. 321–45.
23
Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals.
Am J Epidemiol
1992
;
135
:
1114
–26; discussion 1127–36.
24
Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire.
J Am Diet Assoc
1993
;
93
:
790
–6.
25
Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, Browne ML. Validation of a semi-quantitative food frequency questionnaire: comparison with a 1-year diet record.
J Am Diet Assoc
1987
;
87
:
43
–7.
26
Byrne C, Sinha R, Platz EA, et al. Predictors of dietary heterocyclic amine intake in three prospective cohorts.
Cancer Epidemiol Biomarkers Prev
1998
;
7
:
523
–9.
27
Lee RG. Benign tumors of the colon. In: Haubrich WS, Schaffner F, Berk J, editors. Bockus gastroenterology. Philadelphia: Saunders; 1995. pp. 1715–30.
28
Schut HA, Snyderwine EG. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis.
Carcinogenesis
1999
;
20
:
353
–68.
29
Augustsson K, Skog K, Jagerstad M, Steineck G. Assessment of the human exposure to heterocyclic amines.
Carcinogenesis
1997
;
18
:
1931
–5.
30
Boobis AR, Lynch AM, Murray S, et al. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans.
Cancer Res
1994
;
54
:
89
–94.
31
Lang NP, Butler MA, Massengill J, et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps.
Cancer Epidemiol Biomarkers Prev
1994
;
3
:
675
–82.
32
Minchin RF, Reeves PT, Teitel CH, et al. N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells.
Biochem Biophys Res Commun
1992
;
185
:
839
–44.
33
Chou HC, Lang NP, Kadlubar FF. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
Cancer Res
1995
;
55
:
525
–9.